XOMA Corporation - Product Pipeline Review - 2016 - Global Markets Direct - Market Research

XOMA Corporation - Product Pipeline Review - 2016

XOMA Corporation - Product Pipeline Review - 2016 - Global Markets Direct - Market Research
XOMA Corporation - Product Pipeline Review - 2016
Published Jun 22, 2016
41 pages — Published Jun 22, 2016
Price US$ 1,500.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Global Markets Directs, XOMA Corporation - Product Pipeline Review - 2016, provides an overview of the XOMA Corporations pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by XOMA Corporation, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of XOMA Corporation
- The report provides overview of XOMA Corporation including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses XOMA Corporations pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features XOMA Corporations out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

- Evaluate XOMA Corporations strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for XOMA Corporation
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding XOMA Corporations pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

  
Source:
Document ID
GMDHC08073CDB
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables41
  List of Figures41
XOMA Corporation Snapshot52
  XOMA Corporation Overview51
  Key Information51
  Key Facts61
XOMA Corporation Research and Development Overview72
  Key Therapeutic Areas72
XOMA Corporation Pipeline Review94
  Pipeline Products by Stage of Development91
  Pipeline Products Monotherapy101
  Pipeline Products Out-Licensed Products111
    Out-Licensed Products/Combination Treatment Modalities121
XOMA Corporation Pipeline Products Glance134
  XOMA Corporation Clinical Stage Pipeline Products131
    Phase II Products/Combination Treatment Modalities131
    Phase I Products/Combination Treatment Modalities141
  XOMA Corporation Early Stage Pipeline Products151
    Preclinical Products/Combination Treatment Modalities151
    Discovery Products/Combination Treatment Modalities161
XOMA Corporation Drug Profiles1710
  XOMA-213171
    Product Description171
    Mechanism of Action171
    R&D Progress172
  XOMA-358191
    Product Description191
    Mechanism of Action191
    R&D Progress191
  Monoclonal Antibodies for Undisclosed Disease201
    Product Description201
    Mechanism of Action201
    R&D Progress201
  Monoclonal Antibodies to Antagonize Adrenal Corticotropic Hormone Receptor for Cushing s Disease211
    Product Description211
    Mechanism of Action211
    R&D Progress211
  Monoclonal Antibodies to Antagonize Parathyroid Hormone 1 Receptor for Hyperparathyroidism and Malignancy Induced Hypercalcemia221
    Product Description221
    Mechanism of Action221
    R&D Progress221
  XMet-A231
    Product Description231
    Mechanism of Action231
    R&D Progress231
  XOMA-129241
    Product Description241
    Mechanism of Action241
    R&D Progress241
  XOMA-3-BB251
    Product Description251
    Mechanism of Action251
    R&D Progress251
  Antibody to Modulate GPCR261
    Product Description261
    Mechanism of Action261
    R&D Progress261
XOMA Corporation Pipeline Analysis274
  XOMA Corporation Pipeline Products by Target271
  XOMA Corporation Pipeline Products by Route of Administration281
  XOMA Corporation Pipeline Products by Molecule Type291
  XOMA Corporation Pipeline Products by Mechanism of Action301
XOMA Corporation Recent Pipeline Updates313
XOMA Corporation Dormant Projects341
XOMA Corporation Discontinued Pipeline Products351
  Discontinued Pipeline Product Profiles351
    gevokizumab351
XOMA Corporation Company Statement363
XOMA Corporation Locations And Subsidiaries391
  Head Office391
  Other Locations &Subsidiaries391
Appendix402
  Methodology401
  Coverage401
  Secondary Research401
  Primary Research401
  Expert Panel Validation401
  Contact Us401
  Disclaimer411

Table Of Contents

Global Markets Direct - Market Research—Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information.

About the Author


Cite this Report

  
MLA:
Global Markets Direct - Market Research. "XOMA Corporation - Product Pipeline Review - 2016" Jun 22, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/Global-Markets-Direct-Market-Research/XOMA-Corporation-Product-Pipeline-Review-2016-2088-15989>
  
APA:
Global Markets Direct - Market Research. (2016). XOMA Corporation - Product Pipeline Review - 2016 Jun 22, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/Global-Markets-Direct-Market-Research/XOMA-Corporation-Product-Pipeline-Review-2016-2088-15989>
  
US$ 1,500.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.